Renew
Closing the cycle.
Cellular Renewal and Longevity Research
How is cellular turnover, senescence resolution, and long-term metabolic resilience described in the literature?
The Renew phase organizes research on cellular senescence, autophagy, telomere biology, and NAD+-dependent longevity pathways.
Investigated mechanisms include sirtuin activity, mitochondrial quality control, and proteostasis maintenance.
Reference literature is drawn from geroscience, aging-biology, and metabolic-longevity studies.
- NAD+
Central coenzyme studied across sirtuin signaling, DNA-repair pathways, and longevity research.
- Epitalon
Tetrapeptide investigated in telomere and pineal-regulation literature.
- SS-31 (Elamipretide)
Mitochondria-targeted peptide studied in age-related bioenergetic decline research.
| Short Trial | Standard Trial | Extended Trial | |
|---|---|---|---|
| Research Period | 2 weeks | 4 weeks | 12 weeks |
| Research Schedule | Twice weekly | Twice weekly | Twice weekly |
| Research Dose | 100 mg (160 units) | 100 mg (160 units) | 100 mg (160 units) |
| Total Research Material | 500 mg (800 units) | 1000 mg (1600 units) | 2500 mg (4000 units) |
| Research Vials Needed | 1 × 500 mg vial | 2 × 500 mg vial | 5 × 500 mg vial |
Standardized educational reference: 500 mg NAD+ vial reconstituted with 8 mL bacteriostatic water (62.5 mg per mL; 0.625 mg per unit on a 100-unit insulin reference scale).
The Renew phase concludes Series 1. Subsequent frameworks will organize additional biological systems through the same editorial structure.
For Research Use Only
Not for Human Consumption.
Describe. Never Prescribe.